Skip to main content
Log in

The Obesity Paradox in Chronic Heart Failure: What Does It Mean?

  • Nonpharmacologic Therapy: Surgery, Ventricular Assist Devices, Biventricular Pacing, and Exercise (AK Hasan, Section Editor)
  • Published:
Current Heart Failure Reports Aims and scope Submit manuscript

Abstract

Heart failure (HF) is a growing health problem, at least in part due to the concurrent obesity epidemic plaguing developed countries. However, once a patient develops HF, an elevated BMI appears to confer a survival benefit – a phenomenon termed the “obesity paradox.” The exact explanation for this paradox has been difficult to ascertain. Numerous plausible mechanisms have been asserted, including the fact that obese patients tend to be younger and more symptomatic, leading them to seek medical attention earlier in the course of their HF. Obese patients may also have larger energy reserves that help to offset the catabolic changes seen with HF. Other hypotheses highlight the limitations of BMI as an obesity classifier. The purpose of this review is to examine the various theories for the obesity paradox in HF and discuss the implications for the clinical management of obese patients with HF.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, et al. Heart Disease and Stroke Statistics—2012 Update. Circulation. 2012;125(1):e2–220. doi:10.1161/CIR.0b013e31823ac046.

    Article  PubMed  Google Scholar 

  2. • Lainscak M, von Haehling S, Doehner W, Anker SD. The obesity paradox in chronic disease: facts and numbers. J Cachex Sarcopenia Muscle. 2012;3(1):1–4. doi:10.1007/s13539-012-0059-5. This is a review and opinion of the obesity paradox occuring in a number of chronic disease states and the implication of the obesity paradox for clinicians and researchers of health and disease.

    Article  Google Scholar 

  3. Kenchaiah S, Evans JC, Levy D, Wilson PW, Benjamin EJ, Larson MG, et al. Obesity and the risk of heart failure. N Engl J Med. 2002;347(5):305–13. doi:10.1056/NEJMoa020245.

    Article  PubMed  Google Scholar 

  4. Baena-Díez JM, Byram AO, Grau M, Gómez-Fernández C, Vidal-Solsona M, Ledesma-Ulloa G, et al. Obesity Is an Independent Risk Factor for Heart Failure: Zona Franca Cohort Study. Clin Cardiol. 2010;33(12):760–4. doi:10.1002/clc.20837.

    Article  PubMed  Google Scholar 

  5. Alpert MA, Terry BE, Mulekar M, Cohen MV, Massey CV, Fan TM, et al. Cardiac morphology and left ventricular function in normotensive morbidly obese patients with and without congestive heart failure, and effect of weight loss. Am J Cardiol. 1997;80(6):736–40.

    Article  CAS  PubMed  Google Scholar 

  6. Fonarow GC, Srikanthan P, Costanzo MR, Cintron GB, Lopatin M. Investigators ASACa. An obesity paradox in acute heart failure: analysis of body mass index and inhospital mortality for 108,927 patients in the Acute Decompensated Heart Failure National Registry. Am Heart J. 2007;153(1):74–81.

    Article  PubMed  Google Scholar 

  7. Horwich TB, Fonarow GC, Hamilton MA, MacLellan WR, Woo MA, Tillisch JH. The relationship between obesity and mortality in patients with heart failure. J Am Coll Cardiol. 2001;38(3):789–95.

    Article  CAS  PubMed  Google Scholar 

  8. Arena R, Myers J, Abella J, Pinkstaff S, Brubaker P, Moore B, et al. Influence of etiology of heart failure on the obesity paradox. Am J Cardiol. 2009;104(8):1116–21. doi:10.1016/j.amjcard.2009.05.059.

    Article  PubMed Central  PubMed  Google Scholar 

  9. Curtis JP, Selter JG, Wang Y, Rathore SS, Jovin IS, Jadbabaie F, et al. The obesity paradox: body mass index and outcomes in patients with heart failure. Arch Intern Med. 2005;165(1):55–61. doi:10.1001/archinte.165.1.55.

    Article  PubMed  Google Scholar 

  10. Davos CH, Doehner W, Rauchhaus M, Cicoira M, Francis DP, Coats AJ, et al. Body mass and survival in patients with chronic heart failure without cachexia: the importance of obesity. J Card Fail. 2003;9(1):29–35. doi:10.1054/jcaf.2003.4.

    Article  PubMed  Google Scholar 

  11. • Nagarajan V, Cauthen CA, Starling RC, Tang WH. Prognosis of morbid obesity patients with advanced heart failure. Congest Heart Fail. 2013;19(4):160–4. doi:10.1111/chf.12038. Nicely-done study from the Cleveland Clinic investigating the sometimes-reported “J-shape” survival curve of the obesity paradox. The findings support the idea that based on BMI, morbidly obese patients with HF have significantly higher risk of mortality than their obese counterparts.

    Article  CAS  PubMed  Google Scholar 

  12. Oreopoulos A, Padwal R, Kalantar-Zadeh K, Fonarow GC, Norris CM, McAlister FA. Body mass index and mortality in heart failure: a meta-analysis. Am Heart J. 2008;156(1):13–22. doi:10.1016/j.ahj.2008.02.014.

    Article  PubMed  Google Scholar 

  13. Peterson LR, Waggoner AD, Schechtman KB, Meyer T, Gropler RJ, Barzilai B, et al. Alterations in left ventricular structure and function in young healthy obese women: assessment by echocardiography and tissue Doppler imaging. J Am Coll Cardiol. 2004;43(8):1399–404. doi:10.1016/j.jacc.2003.10.062.

    Article  PubMed  Google Scholar 

  14. Wong CY, O'Moore-Sullivan T, Leano R, Byrne N, Beller E, Marwick TH. Alterations of left ventricular myocardial characteristics associated with obesity. Circulation. 2004;110(19):3081–7. doi:10.1161/01.CIR.0000147184.13872.0F.

    Article  PubMed  Google Scholar 

  15. Koenig SM. Pulmonary complications of obesity. Am J Med Sci. 2001;321(4):249–79.

    Article  CAS  PubMed  Google Scholar 

  16. •• Oreopoulos A, Ezekowitz JA, McAlister FA, Kalantar-Zadeh K, Fonarow GC, Norris CM, et al. Association between direct measures of body composition and prognostic factors in chronic heart failure. Mayo Clin Proc. 2010;85(7):609–17. doi:10.4065/mcp.2010.0103. This is a comprehensive study highlighting the limitation of BMI and the strong correlation between elevated BMI and lean body mass in patients with HF. The higher lean mass with elevated BMI may be the reason for the factors associated with improved prognosis.

    Article  PubMed  Google Scholar 

  17. Lavie CJ, Osman AF, Milani RV, Mehra MR. Body composition and prognosis in chronic systolic heart failure: the obesity paradox. Am J Cardiol. 2003;91(7):891–4.

    Article  PubMed  Google Scholar 

  18. Lee CG, Fujimoto WY, Brunzell JD, Kahn SE, McNeely MJ, Leonetti DL, et al. Intra-abdominal fat accumulation is greatest at younger ages in Japanese-American adults. Diabetes Res Clin Pract. 2010;89(1):58–64. doi:10.1016/j.diabres.2010.03.006.

    Article  PubMed Central  PubMed  Google Scholar 

  19. Hairston KG, Scherzinger A, Foy C, Hanley AJ, McCorkle O, Haffner S, et al. Five-year change in visceral adipose tissue quantity in a minority cohort: the Insulin Resistance Atherosclerosis Study (IRAS) family study. Diabetes Care. 2009;32(8):1553–5. doi:10.2337/dc09-0336.

    Article  PubMed  Google Scholar 

  20. Fantin F, Di Francesco V, Fontana G, Zivelonghi A, Bissoli L, Zoico E, et al. Longitudinal body composition changes in old men and women: interrelationships with worsening disability. J Gerontol A Biol Sci Med Sci. 2007;62(12):1375–81.

    Article  PubMed  Google Scholar 

  21. Amato MC, Guarnotta V, Giordano C. Body composition assessment for the definition of cardiometabolic risk. J Endocrinol Investig. 2013;36(7):537–43. doi:10.3275/8943.

    CAS  Google Scholar 

  22. •• Clark AL, Fonarow GC, Horwich TB. Waist circumference, body mass index, and survival in systolic heart failure: the obesity paradox revisited. J Card Fail. 2011;17(5):374–80. doi:10.1016/j.cardfail.2011.01.009. One of the first studies to investigate the role of fat distribution using waist circumference in the context of the obesity paradox. Also, demonstrated the interaction of BMI and waist circumference.

    Article  PubMed  Google Scholar 

  23. Clark AL, Poole-Wilson PA, Coats AJ. Exercise limitation in chronic heart failure: central role of the periphery. J Am Coll Cardiol. 1996;28(5):1092–102. doi:10.1016/S0735-1097(96)00323-3.

    Article  CAS  PubMed  Google Scholar 

  24. • Lavie CJ, Cahalin LP, Chase P, Myers J, Bensimhon D, Peberdy MA, et al. Impact of cardiorespiratory fitness on the obesity paradox in patients with heart failure. Mayo Clin Proc. 2013;88(3):251–8. doi:10.1016/j.mayocp.2012.11.020. This is an analysis of a very large cohort of patients with HF undergoing cardiopulmonary exercise testing. These results suggest that cardiorespiratory fitness may be more important than BMI in the context of the obesity paradox. This study adds to the idea that there are limits to the obesity paradox.

    Article  PubMed  Google Scholar 

  25. Osman AF, Mehra MR, Lavie CJ, Nunez E, Milani RV. The incremental prognostic importance of body fat adjusted peak oxygen consumption in chronic heart failure. J Am Coll Cardiol. 2000;36(7):2126–31.

    Article  CAS  PubMed  Google Scholar 

  26. Green DJ, Watts K, Maiorana AJ, Kuipers T, Ackland T, O'Driscoll JG. A comparison of methods for the calculation of peak oxygen uptake in patients with heart failure. J Cardpulm Rehabil. 2002;22(2):85–8.

    Article  Google Scholar 

  27. Stelken AM, Younis LT, Jennison SH, Miller DD, Miller LW, Shaw LJ, et al. Prognostic value of cardiopulmonary exercise testing using percent achieved of predicted peak oxygen uptake for patients with ischemic and dilated cardiomyopathy. J Am Coll Cardiol. 1996;27(2):345–52.

    Article  CAS  PubMed  Google Scholar 

  28. Wasserman K. Principles of exercise testing and interpretation : including pathophysiology and clinical applications. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2005.

    Google Scholar 

  29. Arena R, Myers J, Abella J, Pinkstaff S, Brubaker P, Moore B, et al. Determining the preferred percent-predicted equation for peak oxygen consumption in patients with heart failure. Circ Heart Fail. 2009;2(2):113–20. doi:10.1161/CIRCHEARTFAILURE.108.834168.

    Article  PubMed Central  PubMed  Google Scholar 

  30. Harrington D, Anker SD, Chua TP, Webb-Peploe KM, Ponikowski PP, Poole-Wilson PA, et al. Skeletal muscle function and its relation to exercise tolerance in chronic heart failure. J Am Coll Cardiol. 1997;30(7):1758–64.

    Article  CAS  PubMed  Google Scholar 

  31. Anker SD, Swan JW, Volterrani M, Chua TP, Clark AL, Poole-Wilson PA, et al. The influence of muscle mass, strength, fatigability and blood flow on exercise capacity in cachectic and non-cachectic patients with chronic heart failure. Eur Heart J. 1997;18(2):259–69.

    Article  CAS  PubMed  Google Scholar 

  32. Allison DB, Zannolli R, Faith MS, Heo M, Pietrobelli A, VanItallie TB, et al. Weight loss increases and fat loss decreases all-cause mortality rate: results from two independent cohort studies. Int J Obes Relat Metab Disord. 1999;23(6):603–11.

    Article  CAS  PubMed  Google Scholar 

  33. Myers J, Lata K, Chowdhury S, McAuley P, Jain N, Froelicher V. The obesity paradox and weight loss. Am J Med. 2011;124(10):924–30. doi:10.1016/j.amjmed.2011.04.018.

    Article  PubMed  Google Scholar 

  34. Lavie CJ, Milani RV, Artham SM, Patel DA, Ventura HO. The obesity paradox, weight loss, and coronary disease. Am J Med. 2009;122(12):1106–14. doi:10.1016/j.amjmed.2009.06.006.

    Article  CAS  PubMed  Google Scholar 

  35. Lavie CJ, Milani RV, Ventura HO. Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. J Am Coll Cardiol. 2009;53(21):1925–32. doi:10.1016/j.jacc.2008.12.068.

    Article  PubMed  Google Scholar 

  36. Anker SD, Negassa A, Coats AJ, Afzal R, Poole-Wilson PA, Cohn JN, et al. Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study. Lancet. 2003;361(9363):1077–83. doi:10.1016/S0140-6736(03)12892-9.

    Article  CAS  PubMed  Google Scholar 

  37. Pocock SJ, McMurray JJ, Dobson J, Yusuf S, Granger CB, Michelson EL, et al. Weight loss and mortality risk in patients with chronic heart failure in the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programme. Eur Heart J. 2008;29(21):2641–50. doi:10.1093/eurheartj/ehn420.

    Article  PubMed  Google Scholar 

  38. Mehra MR, Kobashigawa J, Starling R, Russell S, Uber PA, Parameshwar J, et al. Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates–2006. J Heart Lung Transplant. 2006;25(9):1024–42. doi:10.1016/j.healun.2006.06.008.

    Article  PubMed  Google Scholar 

  39. • Lindenfeld J, Albert NM, Boehmer JP, Collins SP, Ezekowitz JA, Givertz MM, et al. HFSA 2010 Comprehensive Heart Failure Practice Guideline. J Card Fail. 2010;16(6):e1–194. doi:10.1016/j.cardfail.2010.04.004. These are the current guidelines for the care and treatment of patients with HF in the US.

    Article  PubMed  Google Scholar 

  40. •• Lainscak M, Blue L, Clark AL, Dahlström U, Dickstein K, Ekman I, et al. Self-care management of heart failure: practical recommendations from the Patient Care Committee of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2011;13(2):115–26. doi:10.1093/eurjhf/hfq219. This is the most current recommendation from the Heart Failure Association of the European Society of Cardiology concerning the self-care management of HF. These recommendations are well-supported and provide clear recommendations in a number of important areas related to patient self-care.

    Article  PubMed  Google Scholar 

  41. O'Connor CM, Whellan DJ, Lee KL, Keteyian SJ, Cooper LS, Ellis SJ, et al. Efficacy and Safety of Exercise Training in Patients With Chronic Heart Failure: HF-ACTION Randomized Controlled Trial. JAMA. 2009;301(14):1439–50. doi:10.1001/jama.2009.454.

    Article  PubMed Central  PubMed  Google Scholar 

  42. Sierra-Johnson J, Romero-Corral A, Somers VK, Lopez-Jimenez F, Thomas RJ, Squires RW, et al. Prognostic importance of weight loss in patients with coronary heart disease regardless of initial body mass index. Eur J Cardiovasc Prev Rehabil. 2008;15(3):336–40. doi:10.1097/HJR.0b013e3282f48348.

    Article  PubMed  Google Scholar 

  43. States U. Department of Health and Human Services. 2008 physical activity guidelines for Americans : be active, healthy, and happy! ODPHP publication, vol no U0036. Washington, DC: U.S. Dept. of Health and Human Services; 2008.

    Google Scholar 

  44. Keteyian SJ, Piña IL, Hibner BA, Fleg JL. Clinical role of exercise training in the management of patients with chronic heart failure. J Cardpulm Rehabil Prev. 2010;30(2):67–76. doi:10.1097/HCR.0b013e3181d0c1c1.

    Google Scholar 

Download references

Compliance with Ethics Guidelines

Conflict of Interest

Paul J. Chase, Paul G. Davis, and Daniel R. Bensimhon declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Daniel R. Bensimhon.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chase, P.J., Davis, P.G. & Bensimhon, D.R. The Obesity Paradox in Chronic Heart Failure: What Does It Mean?. Curr Heart Fail Rep 11, 111–117 (2014). https://doi.org/10.1007/s11897-013-0184-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11897-013-0184-2

Keywords

Navigation